TG Therapeutics, IncLogo Design Contest

www.tgtherapeutics.com

TG Therapeutics is a pharmaceutical company that develops novel, targeted agents for treating blood cancers like leukemia and lymphoma. The logo is needed for our first big Phase III trial that we are considering naming "GENUINE" - GENUINE - GlycoEngineered Novel Ublituximab plus Ibrutinib giving high risk CLL patients NEw options

While we are open to variation, it will go on materials that are the company colors so I recommend using blue(PMS 661C) and green (PMS 376C) as the base colors - alternate blue is PMS 2766C

11/6 update: I am attaching a new piece of art we are designing to show where the drugs work for inspiration on adding an innovative science angle but keep simple. . See Pathway Graphic with circled areas (the Purple arrow is where the U drug works and the Yellow arrow is where the I drug works in the BCR pathway on BTK. Ublituximab works as an anti CD20 antibody (look at shapes or info about that), it also is engineered which means it has a higher rate of NK cells inducing cell death. Lots of great images, videos if you google and search BTK or antiCD20 antibody. Video clip also to view at www.bcellsignals.com

Original notes: I will attach the draft advertorial for the trial. There is a placeholder name and logo in the upper right hand side where the GENUINE logo will go. I will attach our company logo. More information on the company and the drugs is available at the website www.tgtherapeutics.com

UPDATE on 11/5/14: General Feedback for all designers based on a team meeting yesterday: For GENUINE, we liked a lot of the designs but there was no real frontrunners, so we have a few comments as you refine or add designs. 1. I emphasized the importance of the "U", the team would like to see better use of the "U" and the "I" since they are a novel drug combination and that the letter sit next to each other. For example, maybe they are taller or more prominent without losing sight of the word genuine when you look at it. 2. The team likes to add the company name but not the website. 2. There is an overall suggestion to keep it simple but also add some science into the logos. Ublituximab works as an anti CD20 antibody (look at shapes or info about that), it also is engineered which means it has a higher rate of NK cells inducing cell death. 3. Still do not want to lose sight of the U being the most important but also the combo of U and I (still shoild be able to read the word. .